SCHEDULE: Pelthos Therapeutics: AME Equities Exits Stake
Beneficial Ownership Amendment
AME Equities LLC and Ruth Friedman have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than 5% of Pelthos Therapeutics Inc. common stock.
Summary
- AME Equities LLC and Ruth Friedman have filed Amendment No. 1 to their Schedule 13G concerning Pelthos Therapeutics Inc.
- This filing serves as an exit filing for both AME Equities LLC and Ruth Friedman.
- As of the event date of June 30, 2025, the reporting persons ceased to be beneficial owners of more than five percent of Pelthos Therapeutics Inc.'s outstanding common stock.
- Both AME Equities LLC and Ruth Friedman now beneficially own 0.00 shares, representing 0% of the common stock class.
- The common stock has a par value of $0.0001 per share.
- The principal business address for both reporting persons is 2011 Bradford Hall Place, Charlotte, NC 28270.
- AME Equities LLC is a North Carolina limited liability company, and Ruth Friedman is a citizen of the United States.
Sentiment
Score: 5
Explanation: The filing is a factual report of a change in beneficial ownership, indicating an exit from a significant stake. It contains no forward-looking statements, financial performance data, or strategic updates from the issuer, thus maintaining a neutral sentiment.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The exit of a significant holder (AME Equities LLC and Ruth Friedman) means a change in the shareholder base, potentially reducing concentration or indicating a shift in institutional interest.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Original Schedule 13G filed by the Reporting Persons with the SEC. |
| 06/30/2025 | Date of event which required the filing of this statement, indicating the reporting persons ceased to be beneficial owners of more than 5%. |
| 08/13/2025 | Date of signature and filing of Amendment No. 1 to Schedule 13G. |
Keywords
Pelthos Therapeutics, AME Equities, Ruth Friedman, Schedule 13G, beneficial ownership, common stock, exit filing, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.